Stein Gunnar Larsen
- MD; PhD
- +47 2293 4052
Publications 2024
Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer
Ann Surg, 280 (5), 745-52 (in press)
DOI 10.1097/SLA.0000000000006492, PubMed 39185557
Hyperthermic intraperitoneal chemotherapy in colorectal cancer
BJS Open, 8 (3)
DOI 10.1093/bjsopen/zrae017, PubMed 38722737
Skin conductance algesimeter is unreliable during sudden perioperative temperature increases
Scand J Pain, 24 (1)
DOI 10.1515/sjpain-2023-0106, PubMed 38607365
Skin conductance algesimeter is unreliable during sudden perioperative temperature increase
Scand J Pain, 24 (1)
DOI 10.1515/sjpain-2024-0058, PubMed 39099226
Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer
J Transl Med, 22 (1), 646
DOI 10.1186/s12967-024-05467-2, PubMed 38982444
Publications 2023
Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
Front Med (Lausanne), 10, 1058914
DOI 10.3389/fmed.2023.1058914, PubMed 36844217
First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
Front Med (Lausanne), 10, 1070362
DOI 10.3389/fmed.2023.1070362, PubMed 36936230
Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
Ann Surg Oncol, 30 (12), 7602-7611
DOI 10.1245/s10434-023-13964-9, PubMed 37481493
Effect of Intraperitoneal 224Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
Technol Cancer Res Treat, 22, 15330338231192902
DOI 10.1177/15330338231192902, PubMed 37574949
Short-term results after robot-assisted surgery for primary rectal cancers requiring beyond total mesorectal excision in multiple compartments
Scand J Surg, 113 (1), 3-12
DOI 10.1177/14574969231200654, PubMed 37787437
Publications 2022
Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study
EClinicalMedicine, 55, 101746
DOI 10.1016/j.eclinm.2022.101746, PubMed 36457647
Publications 2021
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
Br J Cancer, 126 (5), 726-735
DOI 10.1038/s41416-021-01620-6, PubMed 34887523
Metastases in locally advanced rectal cancer undergoing curatively intended treatment
Eur J Surg Oncol, 47 (9), 2377-2383
DOI 10.1016/j.ejso.2021.04.023, PubMed 34049768
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
Acta Oncol, 60 (7), 921-930
DOI 10.1080/0284186X.2021.1918763, PubMed 33966592
[Cancer therapy with isolated limb perfusion]
Tidsskr Nor Laegeforen, 141 (2021-12)
DOI 10.4045/tidsskr.21.0194, PubMed 34505491
Cancer treatment with isolated extremity perfusion
Tidsskr. Nor. Laegeforen., 141 (12), 1186-1189
Correction to: Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of highgrade pseudomyxoma peritonei
Clin Exp Metastasis, 38 (2), 253
DOI 10.1007/s10585-021-10084-0, PubMed 33649933
Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Ann Surg Oncol, 28 (9), 5252-5262
DOI 10.1245/s10434-021-10022-0, PubMed 34019185
Publications 2020
Re-irradiation for recurrent rectal cancer - a single-center experience
Acta Oncol, 59 (5), 534-540
DOI 10.1080/0284186X.2020.1725111, PubMed 32056476
Author response to: Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway
Br J Surg, 107 (7), e222
DOI 10.1002/bjs.11592, PubMed 32364255
Author response to: Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway
Br J Surg, 107 (7), e224
DOI 10.1002/bjs.11596, PubMed 32364249
TaTME and the worse oncological outcome - new data demonstrates a difficult method
Br J Surg, 107 (12), e611
DOI 10.1002/bjs.11850, PubMed 32936942
Publications 2019
ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
Eur J Surg Oncol, 47 (1), 134-138
DOI 10.1016/j.ejso.2019.04.014, PubMed 31036394
Author response to: Comments on: Norwegian moratorium on transanal total mesorectal excision
Br J Surg, 106 (13), 1855
DOI 10.1002/bjs.11374, PubMed 31747073
Norwegian moratorium on transanal total mesorectal excision
Br J Surg, 106 (9), 1120-1121
DOI 10.1002/bjs.11287, PubMed 31304578
Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
Cold Spring Harb Mol Case Stud, 5 (2)
DOI 10.1101/mcs.a003566, PubMed 30862609
Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei
Clin Exp Metastasis, 36 (6), 511-518
DOI 10.1007/s10585-019-09991-0, PubMed 31541325
Transanal total mesorectal excision for rectal cancer has been suspended in Norway
Br J Surg, 107 (1), 121-130
DOI 10.1002/bjs.11459, PubMed 31802481
Publications 2018
Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
Eur J Surg Oncol, 44 (8), 1226-1232
DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115
Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal Cancer
Ann Surg Oncol, 25 (5), 1357-1365
DOI 10.1245/s10434-018-6363-3, PubMed 29497909
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report
World J Surg Oncol, 16 (1), 180
DOI 10.1186/s12957-018-1482-7, PubMed 30185175
Publications 2017
Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
Ann Surg Oncol, 24 (7), 1916-1922
DOI 10.1245/s10434-017-5814-6, PubMed 28224367
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
Br J Surg, 105 (3), 295-301
DOI 10.1002/bjs.10651, PubMed 29168565
Publications 2016
Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome
Clin Oncol (R Coll Radiol), 28 (8), 532-9
DOI 10.1016/j.clon.2016.01.014, PubMed 26888115
Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort
J Surg Oncol, 114 (2), 222-7
DOI 10.1002/jso.24290, PubMed 27173150
Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer
Ann Surg Oncol, 24 (3), 721-728
DOI 10.1245/s10434-016-5621-5, PubMed 27766561
Publications 2015
PDGFR-α and CD117 Expression Pattern in Esophageal Carcinomas
Anticancer Res, 35 (7), 3793-9
PubMed 26124324
PDGFR-alpha and CD117 Expression Pattern in Esophageal Carcinomas
Anticancer Res., 35 (7), 3793-3799
Nuclear, cytoplasmic, and stromal expression of ZEB1 in squamous and small cell carcinoma of the esophagus
APMIS, 123 (12), 1040-7
DOI 10.1111/apm.12473, PubMed 26547370
Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010
Acta Oncol, 54 (10), 1714-22
DOI 10.3109/0284186X.2015.1034876, PubMed 25924970
Prophylactic mesh at end-colostomy construction reduces parastomal hernia rate: a randomized trial
Colorectal Dis, 17 (10), O191-7
DOI 10.1111/codi.13065, PubMed 26179984
Publications 2014
[High-dose-rate brachytherapy in recurrent rectal cancer after conventional recurrence treatment]
Tidsskr Nor Laegeforen, 134 (20), 1929-30
DOI 10.4045/tidsskr.14.1162, PubMed 25350435
Publications 2013
Magnetic resonance-guided histopathology for improved accuracy of tumor response evaluation of neoadjuvant treatment in organ-infiltrating rectal cancer
Radiother Oncol, 107 (2), 178-83
DOI 10.1016/j.radonc.2013.03.017, PubMed 23602370
Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis (Br J Surg 2013; 100: 285-292)
Br J Surg, 100 (2), 292
DOI 10.1002/bjs.8907, PubMed 23239481
Publications 2012
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationale
Tumori, 98 (1), 166-71
DOI 10.1177/030089161209800124, PubMed 22495719
Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei
Eur J Surg Oncol, 38 (10), 969-76
DOI 10.1016/j.ejso.2012.06.552, PubMed 22763244
Publications 2011
Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome
Colorectal Dis, 13 (5), 506-11
DOI 10.1111/j.1463-1318.2010.02256.x, PubMed 20236148
Publications 2009
Adenocarcinomas on the rise--does it influence survival from oesophageal cancer?
Scand J Surg, 98 (4), 214-20
DOI 10.1177/145749690909800404, PubMed 20218417
Locally advanced primary and recurrent rectal cancer: surgical experience after multimodality treatment at the Norwegian Radium Hospital
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 730, 1 b. (flere pag.)
BIBSYS 090176537, ISBN 978-82-8072-301-7
Publications 2008
Molecular detection (k-ras) of exfoliated tumour cells in the pelvis is a prognostic factor after resection of rectal cancer?
BMC Cancer, 8, 213
DOI 10.1186/1471-2407-8-213, PubMed 18655729
Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging
Colorectal Dis, 11 (7), 759-67
DOI 10.1111/j.1463-1318.2008.01649.x, PubMed 18662240
Publications 2007
Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype
BMC Cancer, 7, 116
DOI 10.1186/1471-2407-7-116, PubMed 17603904
Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer
Eur J Surg Oncol, 34 (4), 410-7
DOI 10.1016/j.ejso.2007.05.012, PubMed 17614249
Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence
Colorectal Dis, 10 (1), 48-57
DOI 10.1111/j.1463-1318.2007.01398.x, PubMed 18028472
Publications 2006
[Major surgery on Jehovah's Witnesses]
Tidsskr Nor Laegeforen, 126 (20), 2658-61
PubMed 17057765
Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age
Colorectal Dis, 8 (3), 177-85
DOI 10.1111/j.1463-1318.2005.00877.x, PubMed 16466556
Publications 2005
Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas
Am J Surg, 190 (1), 55-60
DOI 10.1016/j.amjsurg.2004.07.043, PubMed 15972173
Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer
J Surg Oncol, 92 (1), 70-5
DOI 10.1002/jso.20340, PubMed 16180215
Operative treatment of locally recurrent rectal cancer
Recent Results Cancer Res, 165, 136-47
DOI 10.1007/3-540-27449-9_15, PubMed 15865028
Publications 2003
Radical prostatectomy for locally advanced primary or recurrent rectal cancer
Eur J Surg Oncol, 29 (5), 455-8
DOI 10.1016/s0748-7983(03)00030-1, PubMed 12798751
Publications 2000
Can computer-based assessment help us understand children's pain?
Eur J Anaesthesiol, 17 (5), 284-8
DOI 10.1046/j.1365-2346.2000.00655.x, PubMed 10926067
Publications 1999
Invagination of the appendix with carcinoid tumour
Eur J Surg, 165 (10), 993-7
DOI 10.1080/110241599750008152, PubMed 10574110
[Transrectal specimens in recurrent rectal cancer]
Tidsskr Nor Laegeforen, 119 (28), 4170-2
PubMed 10668377
Publications 1973
Oral kinesthetic sensitivity and the perception of speech
Child Dev, 44 (4), 845-8
PubMed 4751306